Feb 15, 2018 9:00am EST Immunovaccine Announces Closing of $14.375 million Bought Deal Offering with Over-allotment option exercised in full
Jan 31, 2018 7:05am EST Published Study Demonstrates the Association Between Immunovaccine’s Proprietary Immune-targeted Delivery Technology and Enhanced Efficacy in Slowing Tumor Progression
Jan 18, 2018 7:05am EST Immunovaccine Names Joseph Sullivan, Experienced Global Pharmaceutical and Vaccine Executive, as Senior Vice President, Business Development
Dec 07, 2017 7:05am EST Immunovaccine and UConn Health Extend Collaboration to Support Advancement of Patient-Specific Immunotherapies to the Clinic
Dec 05, 2017 7:05am EST Immunovaccine Announces Positive Clinical Data from Its Collaborative Combination Immunotherapy Trial in Advanced Ovarian Cancer
Dec 04, 2017 5:05pm EST Immunovaccine to Hold Webcast and Conference Call to Discuss Clinical Data From Its Collaborative Combination Immunotherapy Trial in Advanced Ovarian Cancer
